Literature DB >> 27462384

Status Report from the Scientific Panel on Antibiotic Use in Dermatology of the American Acne and Rosacea Society: Part 1: Antibiotic Prescribing Patterns, Sources of Antibiotic Exposure, Antibiotic Consumption and Emergence of Antibiotic Resistance, Impact of Alterations in Antibiotic Prescribing, and Clinical Sequelae of Antibiotic Use.

James Q Del Rosso1, Guy F Webster2, Ted Rosen3, Diane Thiboutot4, James J Leyden5, Richard Gallo6, Clay Walker7, George Zhanel8, Lawrence Eichenfield9.   

Abstract

Oral and topical antibiotics are commonly prescribed in dermatologie practice, often for noninfectious disorders, such as acne vulgaris and rosacea. Concerns related to antibiotic exposure from both medical and nonmedical sources require that clinicians consider in each case why and how antibiotics are being used and to make appropriate adjustments to limit antibiotic exposure whenever possible. This first article of a three-part series discusses prescribing patterns in dermatology, provides an overview of sources of antibiotic exposure, reviews the relative correlations between the magnitude of antibiotic consumption and emergence of antibiotic resistance patterns, evaluates the impact of alterations in antibiotic prescribing, and discusses the potential relevance and clinical sequelae of antibiotic use, with emphasis on how antibiotics are used in dermatology.

Entities:  

Year:  2016        PMID: 27462384      PMCID: PMC4898580     

Source DB:  PubMed          Journal:  J Clin Aesthet Dermatol        ISSN: 1941-2789


  47 in total

Review 1.  Coping with antibiotic resistance: the impending crisis.

Authors:  I M Gould
Journal:  Int J Antimicrob Agents       Date:  2010-11       Impact factor: 5.283

2.  Prevention of methicillin‐resistant Staphylococcus aureus infection: is Europe winning the fight?

Authors:  Marc J Struelens; Dominique L Monnet
Journal:  Infect Control Hosp Epidemiol       Date:  2010-11       Impact factor: 3.254

3.  MRSA: Farming up trouble.

Authors:  Beth Mole
Journal:  Nature       Date:  2013-07-25       Impact factor: 49.962

4.  Effects of topical erythromycin on ecology of aerobic cutaneous bacterial flora.

Authors:  B R Vowels; D S Feingold; C Sloughfy; A N Foglia; N Konnikov; E Ordoukhanian; P Starkey; J J Leyden
Journal:  Antimicrob Agents Chemother       Date:  1996-11       Impact factor: 5.191

5.  Antimicrobial susceptibility and genetic characteristics of Propionibacterium acnes isolated from patients with acne.

Authors:  Fabiola Schafer; Felix Fich; Marusella Lam; Cynthia Gárate; Aniela Wozniak; Patricia Garcia
Journal:  Int J Dermatol       Date:  2013-02-22       Impact factor: 2.736

Review 6.  Antibiotic resistance to Propionobacterium acnes: worldwide scenario, diagnosis and management.

Authors:  Kabir Sardana; Tanvi Gupta; Vijay K Garg; Sneha Ghunawat
Journal:  Expert Rev Anti Infect Ther       Date:  2015-05-29       Impact factor: 5.091

7.  Effect of antibiotics on the oropharyngeal flora in patients with acne.

Authors:  Ross M Levy; Eric Y Huang; Daniel Roling; James J Leyden; David J Margolis
Journal:  Arch Dermatol       Date:  2003-04

Review 8.  Oral Doxycycline in the Management of Acne Vulgaris: Current Perspectives on Clinical Use and Recent Findings with a New Double-scored Small Tablet Formulation.

Authors:  James Q Del Rosso
Journal:  J Clin Aesthet Dermatol       Date:  2015-05

9.  In vivo antibacterial effects of tretinoin-clindamycin and clindamycin alone on Propionibacterium acnes with varying clindamycin minimum inhibitory.

Authors:  James J Leyden
Journal:  J Drugs Dermatol       Date:  2012-12       Impact factor: 2.114

10.  Antibiotic-resistant acne: lessons from Europe.

Authors:  J I Ross; A M Snelling; E Carnegie; P Coates; W J Cunliffe; V Bettoli; G Tosti; A Katsambas; J I Galvan Peréz Del Pulgar; O Rollman; L Török; E A Eady; J H Cove
Journal:  Br J Dermatol       Date:  2003-03       Impact factor: 9.302

View more
  10 in total

Review 1.  SARECYCLINE AND THE NARROW-SPECTRUM TETRACYCLINE CONCEPT: Currently Available Data and Potential Clinical Relevance in Dermatology.

Authors:  James Q Del Rosso
Journal:  J Clin Aesthet Dermatol       Date:  2020-10-01

Review 2.  Tetracyclines-An Important Therapeutic Tool for Dermatologists.

Authors:  Malgorzata Orylska-Ratynska; Waldemar Placek; Agnieszka Owczarczyk-Saczonek
Journal:  Int J Environ Res Public Health       Date:  2022-06-13       Impact factor: 4.614

3.  Sarecycline Demonstrates Clinical Effectiveness against Staphylococcal Infections and Inflammatory Dermatoses: Evidence for Improving Antibiotic Stewardship in Dermatology.

Authors:  Ayman Grada; Mahmoud A Ghannoum; Christopher G Bunick
Journal:  Antibiotics (Basel)       Date:  2022-05-27

Review 4.  Tetracyclines and bone: Unclear actions with potentially lasting effects.

Authors:  Amy J Warner; Jessica D Hathaway-Schrader; Rena Lubker; Christopher Davies; Chad M Novince
Journal:  Bone       Date:  2022-03-03       Impact factor: 4.626

5.  The Role of Topical Antibiotic Prophylaxis in Oculofacial Plastic Surgery: A Randomized Controlled Study.

Authors:  Davin C Ashraf; Oluwatobi O Idowu; Qinyun Wang; Tak YeEun; Thomas S Copperman; Sombat Tanaboonyawat; Benjamin F Arnold; Catherine E Oldenburg; M Reza Vagefi; Robert C Kersten
Journal:  Ophthalmology       Date:  2020-07-19       Impact factor: 12.079

6.  Sarecycline treatment for acne vulgaris: Rationale for weight-based dosing and limited impact of food intake on clinical efficacy.

Authors:  Ayman Grada; James Q Del Rosso; Emmy Graber; Christopher G Bunick; Linda Stein Gold; Angela Y Moore; Hilary Baldwin; Zaidal Obagi; Giovanni Damiani; Timothy Carrothers; Brian McNamee; Eva Hanze
Journal:  Dermatol Ther       Date:  2021-12-30       Impact factor: 3.858

Review 7.  Oral Spironolactone for Acne Vulgaris in Adult Females: A Hybrid Systematic Review.

Authors:  Alison M Layton; E Anne Eady; Heather Whitehouse; James Q Del Rosso; Zbys Fedorowicz; Esther J van Zuuren
Journal:  Am J Clin Dermatol       Date:  2017-04       Impact factor: 7.403

Review 8.  Sarecycline: a narrow spectrum tetracycline for the treatment of moderate-to-severe acne vulgaris.

Authors:  Angela Yen Moore; Jean Elizze M Charles; Stephen Moore
Journal:  Future Microbiol       Date:  2019-09-02       Impact factor: 3.165

9.  Minocycline and Its Impact on Microbial Dysbiosis in the Skin and Gastrointestinal Tract of Acne Patients.

Authors:  Katherine G Thompson; Barbara M Rainer; Corina Antonescu; Liliana Florea; Emmanuel F Mongodin; Sewon Kang; Anna L Chien
Journal:  Ann Dermatol       Date:  2020-01-09       Impact factor: 1.444

10.  Selective targeting of skin pathobionts and inflammation with topically applied lactobacilli.

Authors:  Sarah Lebeer; Eline F M Oerlemans; Ingmar Claes; Tim Henkens; Lize Delanghe; Sander Wuyts; Irina Spacova; Marianne F L van den Broek; Ines Tuyaerts; Stijn Wittouck; Ilke De Boeck; Camille N Allonsius; Filip Kiekens; Julien Lambert
Journal:  Cell Rep Med       Date:  2022-02-15
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.